STOCK TITAN
  1. Home
  2. Sec-filings
  3. TNON
  4. [Form 4] Tenon Medical, Inc. Insider Trading Activity

TNON Form 4: 21,464 RSUs granted to director with 2026 vesting

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Tenon Medical (TNON) filed a Form 4 reporting an equity award to a director. On 10/13/2025, the reporting person acquired 21,464 restricted stock units (RSUs), each representing the right to receive one share of common stock. The derivative security price is listed as $0.

According to the filing, vesting occurs in two equal tranches: 50% on January 1, 2026 and the remaining 50% on July 31, 2026. Following the transaction, 21,464 derivative securities are beneficially owned on a direct basis.

Positive

  • None.

Negative

  • None.

Insights

Director granted 21,464 RSUs, vesting in two 2026 tranches.

The filing shows an award of 21,464 RSUs on 10/13/2025. RSUs are a form of deferred equity that convert into common shares upon vesting, aligning director compensation with shareholder value without immediate cash outlay.

The vesting schedule is split: 50% on January 1, 2026 and 50% on July 31, 2026. The derivative security price is $0, typical for RSU grants. Ownership is direct, with 21,464 derivative securities beneficially owned after the transaction.

Insider WEIGLE ROBERT K
Role Director
Type Security Shares Price Value
Grant/Award Restricted Stock Units 21,464 $0.00 --
Holdings After Transaction: Restricted Stock Units — 21,464 shares (Direct)
Footnotes (1)
  1. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Fifty percent (50%) of the total number of restricted stock units shall vest and automatically convert into shares of common stock of the Issuer (on one-for-one basis) on January 1, 2026 and the remaining fifty percent (50%) shall vest and automatically convert into the shares of common stock of the Issuer (on one-for-one basis) on July 31, 2026.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
WEIGLE ROBERT K
(Last) (First) (Middle)
104 COOPER COURT
(Street)
LOS GATOS CA 95032
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Tenon Medical, Inc. [ TNON ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/13/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) 10/13/2025 A 21,464 (2) (2) Common Stock 21,464 $0 21,464 D
Explanation of Responses:
1. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.
2. Fifty percent (50%) of the total number of restricted stock units shall vest and automatically convert into shares of common stock of the Issuer (on one-for-one basis) on January 1, 2026 and the remaining fifty percent (50%) shall vest and automatically convert into the shares of common stock of the Issuer (on one-for-one basis) on July 31, 2026.
/s/ Robert Weigle 10/15/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did Tenon Medical (TNON) report on this Form 4?

An acquisition of 21,464 restricted stock units (RSUs) by a director on 10/13/2025.

How many RSUs were granted in the TNON filing?

The filing reports 21,464 RSUs, each RSU representing one share of common stock.

What is the vesting schedule for the 21,464 TNON RSUs?

50% vest on January 1, 2026 and 50% vest on July 31, 2026.

What price is shown for the RSUs in the TNON Form 4?

The derivative security price is listed as $0, standard for RSU awards.

What is the ownership form after the TNON RSU transaction?

The filing lists direct (D) ownership of 21,464 derivative securities after the transaction.

Who signed the TNON Form 4 and when?

It was signed by /s/ Robert Weigle on 10/15/2025.